1st Quarter - Report

HOSPIRA, INC. for HOSPIRA INC

Firm
Client
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

The Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act relating to delay of the ACA medical device tax.

LobbyistCovered position, as disclosed
JULIANA REED —
WENDY SUSSMAN —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to drug approvals at the FDA including biosimilars; issues related to drug shortages; issues related to heroin and opioid overdose.

LobbyistCovered position, as disclosed
JULIANA REED —
WENDY SUSSMAN —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Pharmacy PHA

Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products).

LobbyistCovered position, as disclosed
JULIANA REED —
WENDY SUSSMAN —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.